A Post-Approval Registry for Exablate 4000 Type 1.0 and Type 1.1 for Unilateral Pallidotomy for the Treatment of Advanced, Idiopathic Parkinson's Disease With Medication-refractory Moderate to Severe Motor Complications (NCT05539196)
🩺 Plain-English Summary (8th-Grade Level)
This registry is a prospective, multicenter, international, single arm, observational post-approval registry with follow-up at 3, 6, and 12 months, and annually for 5 years. The proposed registry will enroll 60 subjects and will be conducted at approximately 10 centers worldwide.
Who can join: Review the eligibility criteria below.
Location: University of Maryland, Baltimore — Baltimore, Maryland
Age range: 30 Years to 99 Years
🧪 Interventions in This Study
📋 "Do I Qualify?" — 1-Minute Self Screener
Instant ChecklistFull eligibility criteria are available on the official NIH protocol. View the criteria ↗
📍 All Participating Trial Locations (5 Sites)
- University of Maryland, Baltimore — Baltimore, Maryland
- Weill Cornell Medicine — New York, New York
- University of Pennsylvania — Philadelphia, Pennsylvania
- University of Texas Southwestern Medical Center — Dallas, Texas
- Ohnishi Neurological Center — Akashi, Hyōgo
📞 Contact the Study Coordinator
Phone: (214) 304-8265
Email: clinicalresearchquestions@insightec.com
Coordinator details come directly from the registered NIH protocol. Confirm the study is still recruiting before traveling.
💰 Cost, Insurance & Patient Rights
- 100% Free Items: The investigational treatment and protocol-required procedures are supplied at zero cost by the sponsor.
- Routine Patient Care: Under federal law (ACA § 2709) and many state statutes, routine care costs are covered during participation.
- Voluntary Participation: You may withdraw at any time without affecting your standard medical care.
More studies in Movement Disorders
- ExAblate Transcranial MRgFUS for the Management of Treatment-Refractory Movement Disorders — Toronto, Ontario
- Handwriting Analysis in Movement Disorders. — London, Ontario
- Botulinum Toxin for the Treatment of Involuntary Movement Disorders — Bethesda, Maryland
- Neurophysiological, Behavioral, and Cognitive Networks in Movement Disorders — Birmingham, Alabama
- Neurophysiology of the Basal Ganglia, Thalamus, and Cerebellum in Patients With Movement Disorders — Philadelphia, Pennsylvania
- Towards Restoring Complex Movement After Paralysis: Algorithm Development With Healthy Participants — Los Angeles, California
Explore by condition: All Movement Disorders clinical trials
💡 How to Participate
- Check the checklist above to see if you may qualify.
- Contact the study coordinator using the phone/email above.
- Ask about the visit schedule, what is covered at no cost, and any travel support.
- Confirm with your own doctor before making a decision.